Stada Enjoys Strong First Half With Sales Up By A Quarter
A combination of acquisitions, market share gains and successful product launches helped push Stada’s Consumer Healthcare sales up by a quarter in the first half as the German firm weathered tough macroeconomic conditions.
You may also be interested in...
A round-up of the latest appointments in the consumer health market: Alliance Pharma appoints COO; Stada confirms Döbler as permanent CFO; and Cann Group hires CEO from Ipsen.
87 of the top 100 German OTC manufacturers are now reporting inflation-driven price increases, up from 72 at the same point last year. Sempora Consulting suggests a number of strategies to address the current economic challenges companies face.
Germany-based Stada has appointed its head of mid-sized European markets, Rudolf Bär, as its UK lead.